SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002048
Accepted
2024-07-03 00:15:06
Documents
1
Effectiveness Date
2024-07-02
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 609
  Complete submission text file 9999999995-24-002048.txt   2029
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-233767 | Film No.: 241098142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)